Safety of HRX215 in Patients After Minor and Major Liver Resection
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this clinical trial is to learn if HRX215 is safe, tolerable and active in adults who have undergone liver resection due to colorectal carcinoma metastases. The objectives are: 1. to learn about the safety and tolerability of HRX215 2. to learn about how the body absorbs, distributes, and gets rid of HRX215. 3. to learn about clinical activity of HRX215 Researchers will compare HRX215 to a placebo (a look-alike substance that contains no drug) to investigate safety, tolerability and clinical activity in participants taking HRX215.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci z przerzutami raka jelita grubego w wątrobie, którzy mają mieć usuniętą część wątroby.
- •Pacjenci stabilni 1-3 dni po mniejszej operacji wątroby (tylko dla części 1 badania).
- •Pacjenci po większej operacji wątroby (tylko dla części 2 i 3 badania).
- •Niskie ryzyko problemów z wątrobą po operacji.
✗ Disqualifies
- •Marskość wątroby.
- •Obecność płynu w jamie brzusznej przed operacją.
- •Inny nowotwór wątroby lub dróg żółciowych.
- •Wskaźnik BMI powyżej 35.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- July 10, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (12)
Johns Hopkins Hospital
Baltimore, United States
Mayo Clinic
Rochester, United States
Cleveland Clinic
Cleveland, United States
Centre Hospitalier Régional Universitaire de Lille (CHRU) Hôpital Claude Huriez
Lille, France
Hôpital Paul-Brousse - Centre Hepato-Biliaire (CHB)
Villejuif, France
Univ. Tuebingen - Universitaetsklinik fuer Allgemeine, Viszeral- und Transplantationschirurgie
Tübingen, Germany
Rabin Medical Center
Petah Tikva, Israel
Sheba Medical Center
Ramat Gan, Israel
Tel-Aviv Sourasky MC
Tel Aviv, Israel
Hospital Universitario La Paz
Madrid, Spain
South Texas Accelerated Research Therapeutics Madrid - CIOCC - Universitario Sanchinarro
Madrid, Spain
Consorci Hospital General Universitari de València
Valencia, Spain
Trial contact
Wolfgang Albrecht, PhD NC
Linda Greenbaum, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/3/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.